439 related articles for article (PubMed ID: 35335920)
1. Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application.
Lombardo D; Kiselev MA
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335920
[TBL] [Abstract][Full Text] [Related]
2. Advancements in liposomal formulations: A comprehensive exploration of industrial production techniques.
Sameer Khan M; Gupta G; Alsayari A; Wahab S; Sahebkar A; Kesharwani P
Int J Pharm; 2024 Jun; 658():124212. PubMed ID: 38723730
[TBL] [Abstract][Full Text] [Related]
3. Constant pressure-controlled extrusion method for the preparation of Nano-sized lipid vesicles.
Morton LA; Saludes JP; Yin H
J Vis Exp; 2012 Jun; (64):. PubMed ID: 22760481
[TBL] [Abstract][Full Text] [Related]
4. Novel methods for liposome preparation.
Patil YP; Jadhav S
Chem Phys Lipids; 2014 Jan; 177():8-18. PubMed ID: 24220497
[TBL] [Abstract][Full Text] [Related]
5. Design of multifunctional liposome-quantum dot hybrid nanocarriers and their biomedical application.
Qu W; Zuo W; Li N; Hou Y; Song Z; Gou G; Yang J
J Drug Target; 2017 Sep; 25(8):661-672. PubMed ID: 28438041
[TBL] [Abstract][Full Text] [Related]
6. Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.
Lombardo D; Calandra P; Barreca D; Magazù S; Kiselev MA
Nanomaterials (Basel); 2016 Jun; 6(7):. PubMed ID: 28335253
[TBL] [Abstract][Full Text] [Related]
7. Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes.
Pande S
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):428-440. PubMed ID: 37594208
[TBL] [Abstract][Full Text] [Related]
8. Polydopamine-Modified Liposomes: Preparation and Recent Applications in the Biomedical Field.
Maurelli AM; De Leo V; Catucci L
ACS Omega; 2024 Jun; 9(23):24105-24120. PubMed ID: 38882106
[TBL] [Abstract][Full Text] [Related]
9. Liposomes containing nanoparticles: preparation and applications.
De Leo V; Maurelli AM; Giotta L; Catucci L
Colloids Surf B Biointerfaces; 2022 Oct; 218():112737. PubMed ID: 35933888
[TBL] [Abstract][Full Text] [Related]
10. Liposome: composition, characterisation, preparation, and recent innovation in clinical applications.
Ahmed KS; Hussein SA; Ali AH; Korma SA; Lipeng Q; Jinghua C
J Drug Target; 2019 Aug; 27(7):742-761. PubMed ID: 30239255
[TBL] [Abstract][Full Text] [Related]
11. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
12. Liposome bilayer stability: emphasis on cholesterol and its alternatives.
Nsairat H; Ibrahim AA; Jaber AM; Abdelghany S; Atwan R; Shalan N; Abdelnabi H; Odeh F; El-Tanani M; Alshaer W
J Liposome Res; 2024 Mar; 34(1):178-202. PubMed ID: 37378553
[TBL] [Abstract][Full Text] [Related]
13. Recent Advancements in Polymer/Liposome Assembly for Drug Delivery: From Surface Modifications to Hybrid Vesicles.
De Leo V; Milano F; Agostiano A; Catucci L
Polymers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810273
[TBL] [Abstract][Full Text] [Related]
14. Liposomes as nanocarriers for anti-HIV therapy.
Chopra S; Venkatesan N; Betageri GV
Drug Deliv Transl Res; 2013 Oct; 3(5):471-8. PubMed ID: 25788354
[TBL] [Abstract][Full Text] [Related]
15. A Sojourn on Liposomal Delivery System: Recent Advances and Future Prospects.
Kaur S; Singh D
Assay Drug Dev Technol; 2023; 21(2):48-64. PubMed ID: 36856471
[No Abstract] [Full Text] [Related]
16. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
17. Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances.
Jash A; Ubeyitogullari A; Rizvi SSH
J Mater Chem B; 2021 Jun; 9(24):4773-4792. PubMed ID: 34027542
[TBL] [Abstract][Full Text] [Related]
18. Polymeric Lipid Hybrid Nanoparticles (PLNs) as Emerging Drug Delivery Platform-A Comprehensive Review of Their Properties, Preparation Methods, and Therapeutic Applications.
Sivadasan D; Sultan MH; Madkhali O; Almoshari Y; Thangavel N
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452251
[TBL] [Abstract][Full Text] [Related]
19. Liposomes as Versatile Platform for Cancer Theranostics: Therapy, Bio-imaging, and Toxicological Aspects.
Mehta S; Kulkarni S; Nikam AN; Padya BS; Pandey A; Mutalik S
Curr Pharm Des; 2021; 27(17):1977-1991. PubMed ID: 33719968
[TBL] [Abstract][Full Text] [Related]
20. Optimizing liposomes for delivery of Bowman-Birk protease inhibitors - Platforms for multiple biomedical applications.
Joanitti GA; Sawant RS; Torchilin VP; Freitas SM; Azevedo RB
Colloids Surf B Biointerfaces; 2018 Jul; 167():474-482. PubMed ID: 29723819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
